$GILD Company News The market puts a few feather
Post# of 144503
Posted On: 01/28/2014 12:55:42 PM
$GILD Company News
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Are the prevailing technicals bullish, or bearish? 11:55 a.m. Jan. 17, 2014 - Michael Ashbaugh
U.S. stocks drop on Goldman, Citi; Nasdaq edges up 4:08 p.m. Jan. 16, 2014 - Laura Mandaro
Nu Skin sinks on China probe; Best Buy hits 6-month low 4:05 p.m. Jan. 16, 2014 - Sue Chang
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 4:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 3:09 p.m. Jan. 16, 2014 - Russ Britt
Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Biotechs - especially Biogen, Celgene, Gilead - have further to rise, DB says 57 min ago - Seeking Alpha
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised 10:22 a.m. Today - TheStreet.com
Big cap biotech pushed at Deutsche 9:12 a.m. Today - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Today - Seeking Alpha
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Today - Seeking Alpha
Growth Portfolio Super Bowl: Gilead Vs. Polaris 12:09 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
CHMP Positive on Bayer's Riociguat - Analyst Blog 4:30 p.m. Jan. 27, 2014 - Zacks.com
Top 2013 Drug Approvals: Pharma Stocks 3:58 p.m. Jan. 27, 2014 - Seeking Alpha
Obamacare Boosts Health Funds 11:26 a.m. Jan. 27, 2014 - TheStreet.com
Payers revel against Gilead over cost of hepatitis C pill 7:14 a.m. Jan. 27, 2014 - Seeking Alpha
Payers rebel against Gilead over cost of hepatitis C pill 7:14 a.m. Jan. 27, 2014 - Seeking Alpha
Liver Drug Race: Intercept Pharma Vs. Rivals 7:24 p.m. Jan. 26, 2014 - Seeking Alpha
Weekly CFO Sells Highlight: Forest Laboratories Inc, U.S. ... 4:06 p.m. Jan. 26, 2014 - GuruFocus.com
5 New Drugs That Could Be Blockbusters in 2014 3:42 a.m. Jan. 25, 2014 - Barrons.com
BMY Pummeled After Earnings, But Bristol-Myers Squibb Stock Still a Buy 10:20 a.m. Jan. 24, 2014 - InvestorPlace.com
Amidst Huge Unknowns, Conatus Pharmaceuticals Worth A Closer Look 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Biotech Bull Market Key Trend No. 1: 5 Large Cap Biopharmas Plus 2 11:39 a.m. Jan. 23, 2014 - Seeking Alpha
Gilead Sciences: Will It Double Your Money Again In 2014? 2:22 a.m. Jan. 23, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's Wild Ride 8:18 p.m. Jan. 22, 2014 - TheStreet.com
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
The market puts a few feathers in its cap 1:58 p.m. Jan. 23, 2014 - The Trading Deck
Are the prevailing technicals bullish, or bearish? 11:55 a.m. Jan. 17, 2014 - Michael Ashbaugh
U.S. stocks drop on Goldman, Citi; Nasdaq edges up 4:08 p.m. Jan. 16, 2014 - Laura Mandaro
Nu Skin sinks on China probe; Best Buy hits 6-month low 4:05 p.m. Jan. 16, 2014 - Sue Chang
S&P 500 drops from record, but Nasdaq ekes out gain: Stock market live blog recap 4:02 p.m. Jan. 16, 2014 - blogs.marketwatch.com
Speculators turn the heat up to ‘soft boil’ 3:55 p.m. Jan. 16, 2014 - The Trading Deck
Mounting optimism for hepatitis C drug boosts Gilead to lead S&P 500 3:09 p.m. Jan. 16, 2014 - Russ Britt
Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Biotechs - especially Biogen, Celgene, Gilead - have further to rise, DB says 57 min ago - Seeking Alpha
Idenix Pharma CEO Speaks On Plans for the $107 Million Just Raised 10:22 a.m. Today - TheStreet.com
Big cap biotech pushed at Deutsche 9:12 a.m. Today - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 5:40 a.m. Today - Seeking Alpha
Cramer's Mad Money - We Are In Reset Mode (1/27/14) 5:06 a.m. Today - Seeking Alpha
Growth Portfolio Super Bowl: Gilead Vs. Polaris 12:09 a.m. Today - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Market Reset 8:33 p.m. Jan. 27, 2014 - TheStreet.com
CHMP Positive on Bayer's Riociguat - Analyst Blog 4:30 p.m. Jan. 27, 2014 - Zacks.com
Top 2013 Drug Approvals: Pharma Stocks 3:58 p.m. Jan. 27, 2014 - Seeking Alpha
Obamacare Boosts Health Funds 11:26 a.m. Jan. 27, 2014 - TheStreet.com
Payers revel against Gilead over cost of hepatitis C pill 7:14 a.m. Jan. 27, 2014 - Seeking Alpha
Payers rebel against Gilead over cost of hepatitis C pill 7:14 a.m. Jan. 27, 2014 - Seeking Alpha
Liver Drug Race: Intercept Pharma Vs. Rivals 7:24 p.m. Jan. 26, 2014 - Seeking Alpha
Weekly CFO Sells Highlight: Forest Laboratories Inc, U.S. ... 4:06 p.m. Jan. 26, 2014 - GuruFocus.com
5 New Drugs That Could Be Blockbusters in 2014 3:42 a.m. Jan. 25, 2014 - Barrons.com
BMY Pummeled After Earnings, But Bristol-Myers Squibb Stock Still a Buy 10:20 a.m. Jan. 24, 2014 - InvestorPlace.com
Amidst Huge Unknowns, Conatus Pharmaceuticals Worth A Closer Look 9:30 a.m. Jan. 24, 2014 - Seeking Alpha
Biotech Bull Market Key Trend No. 1: 5 Large Cap Biopharmas Plus 2 11:39 a.m. Jan. 23, 2014 - Seeking Alpha
Gilead Sciences: Will It Double Your Money Again In 2014? 2:22 a.m. Jan. 23, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: The Market's Wild Ride 8:18 p.m. Jan. 22, 2014 - TheStreet.com
Gilead Announces Executive Promotions 5:00 p.m. Jan. 27, 2014 - BusinessWire - BZX
European Commission Grants Marketing Authorization for Gilead’s Sovaldi® (Sofosbuvir) for the Treatment of Chronic Hepatitis C Infection 9:09 a.m. Jan. 17, 2014 - BusinessWire - BZX
Acceptance of NDA for Review, Acquisitions of Development Rights, Earnings Release Schedulesm and New Leaders - Research Report on Gilead, Lilly, Allergan, Incyte, and Varian Medical Systems 8:00 a.m. Jan. 16, 2014 - PR Newswire - PRF
U.S. FDA Accepts New Drug Application for Gilead’s Idelalisib for the Treatment of Refractory Indolent Non-Hodgkin’s Lymphoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Biotoscana agrees to acquire United Medical to expand commercial presence in Brazil and create a leading regional specialty pharmaceutical company in South America 1:15 a.m. Jan. 13, 2014 - BusinessWire - BZX
Gilead Sciences to Present at the 32nd Annual JPMorgan Healthcare Conference on Monday, January 13 5:00 p.m. Jan. 10, 2014 - BusinessWire - BZX
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Jan. 9, 2014 - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼